Join us for a special 60‑minute webinar marking the first anniversary of the European Regulation on Health Technology Assessment (EU HTAR) coming into effect — a milestone that has reshaped the way health technologies are assessed and accessed across Europe.
Over the past year, the Joint Clinical Assessment (JCA) process has moved from concept to reality, influencing how innovators, payers, and patients navigate the evolving HTA landscape. But where did this journey begin? Where are we now? And what’s next?
Guiding us through these questions will be:
- Suzette Matthijsse — Senior Director at Lumanity and JCA Lead, bringing first-hand expertise from supporting clients on EU HTAR projects since 2022
- Neil Grubert — Internationally recognized market access specialist, offering a global perspective on the Regulation’s implications and opportunities
Together, they will:
- Reflect on the road to the EU HTAR launch
- Share key learnings from its first year in practice
- Explore future directions and challenges for HTA and market access in Europe
Whether you’re a policymaker, market access professional, industry stakeholder, or simply passionate about the evolving European health technology landscape, this webinar will provide insights you won’t want to miss.
